| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/09/1995 | CA2168430A1 Hmg2 promoter expression system and post-harvest production of gene products in plants and plant cell cultures |
| 02/09/1995 | CA2168349A1 Intracellular immunization |
| 02/09/1995 | CA2168348A1 Novel stem cell marker |
| 02/09/1995 | CA2168245A1 Polynucleotide decoys that inhibit mhc-ii expression and uses thereof |
| 02/09/1995 | CA2168243A1 Liposomal antisense methyl phosphonate oligonucleotides and methods for their preparation and use |
| 02/09/1995 | CA2168230A1 Human antibodies against varicella-zoster virus |
| 02/09/1995 | CA2168098A1 Jak kinases and regulation of cytokine signal transduction |
| 02/09/1995 | CA2167835A1 Monoclonal iga antibody against respiratory syncytial virus |
| 02/09/1995 | CA2167680A1 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 02/08/1995 | EP0637336A1 Mn gene and protein |
| 02/08/1995 | EP0637333A1 Ifn receptors recognition factors, protein sequences and methods of use thereof |
| 02/08/1995 | EP0637201A1 Method for inducing tumor immunity |
| 02/07/1995 | US5387758 Production of improved rapeseed exhibiting a reduced saturated fatty acid content |
| 02/07/1995 | US5387756 Modification of plant metabolism |
| 02/07/1995 | US5387676 MN gene and protein |
| 02/07/1995 | US5387583 Compositions containing corticosteroids or analogues thereof and corticosteroid buffering effective amounts of 5-androstene 3B, 17B or 5-androstene 3B, 7B, 17B triol or analogues thereof |
| 02/07/1995 | CA1334288C Method for production of human tissue type plasminogen activator |
| 02/02/1995 | WO1995003422A1 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 02/02/1995 | WO1995003414A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 02/02/1995 | WO1995003411A1 Agonists and antagonists of human interleukin-10 |
| 02/02/1995 | WO1995003409A1 Analogues of an anti-thrombin polypeptide and process for their preparation |
| 02/02/1995 | WO1995003408A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | WO1995003406A2 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 02/02/1995 | WO1995003402A1 EXPRESSION OF HUMAN INTERLEUKIN-1β IN A TRANSGENIC ANIMAL |
| 02/02/1995 | WO1995003398A1 Enucleation of oocytes |
| 02/02/1995 | WO1995003397A1 Transgenic animal model for cognitive disorders |
| 02/02/1995 | WO1995003335A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 02/02/1995 | WO1995003328A2 Melanoma-inhibiting protein |
| 02/02/1995 | WO1995003326A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | WO1995003324A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003323A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003318A1 Recombinant c140 receptor and its agonists and antagonists |
| 02/02/1995 | WO1995003062A1 Methods and compositions for preventing immune rejection of solid organ grafts |
| 02/02/1995 | WO1994029447A3 Dna coding for the human thyrotropin-releasing hormone receptor |
| 02/02/1995 | WO1994029442A3 Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
| 02/02/1995 | CA2168232A1 Recombinant c140 receptor and its agonists and antagonists |
| 02/02/1995 | CA2168110A1 Agonists and antagonists of human interleukin-10 |
| 02/02/1995 | CA2168096A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 02/02/1995 | CA2167581A1 Transgenic animal model for cognitive disorders |
| 02/02/1995 | CA2167580A1 Expression of human interleukin-1.beta. in a transgenic animal |
| 02/02/1995 | CA2167303A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | CA2167302A1 Oncoprotein protein kinase |
| 02/02/1995 | CA2167091A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | CA2166890A1 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 02/01/1995 | EP0636694A2 Human and human-like thymopoietin, method for its production and recombinant DNA sequences encoding it |
| 02/01/1995 | EP0636184A1 Media for isolation and stabilization of cells |
| 02/01/1995 | EP0636183A1 Compositions and methods for protein structural determinations |
| 02/01/1995 | EP0636182A1 Antibodies for treatment and prevention of respiratory syncytial virus infection |
| 02/01/1995 | EP0636181A1 Newly characterised oxalate oxidase and uses therefor |
| 02/01/1995 | EP0636179A1 Oil-body proteins as carriers of high-value peptides in plants |
| 02/01/1995 | EP0636178A1 Protocadherin, their autibodies and uses |
| 02/01/1995 | EP0636177A1 ISOLATION, CHARACTERIZATION, AND USE OF THE HUMAN $g(b) SUBUNIT OF THE HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E |
| 02/01/1995 | EP0636176A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily |
| 02/01/1995 | EP0535150B1 Human macrophage inflammatory protein 2-beta |
| 01/31/1995 | US5386025 Calcium channel compositions and methods |
| 01/31/1995 | US5385840 Respiratory system |
| 01/31/1995 | US5385836 Nonwoven fabric coated with a mixture of silk fibroin, gelatin and insolubilized chitosan for use as a carrier for animal cells |
| 01/31/1995 | CA1334177C Production of chimeric antibodies by homologous recombination |
| 01/31/1995 | CA1334176C Monoclonal antibody recognizing gamma atrial natriuretic polypeptide |
| 01/31/1995 | CA1334175C Plant promoter and method for using same |
| 01/30/1995 | CA2126523A1 Jak kinases and regulation of cytokine signal transduction |
| 01/27/1995 | CA2128653A1 Nucleotide sequences allowing the replication and conservation of a genetic information in animal cells |
| 01/26/1995 | WO1995002823A1 Identification of ligands by selective amplification of cells transfected with receptors |
| 01/26/1995 | WO1995002697A1 Defective adenovirus vectors and use thereof in gene therapy |
| 01/26/1995 | WO1995002696A1 Fruit specific promoters |
| 01/26/1995 | WO1995002692A1 Modified alpha-lactalbumin |
| 01/26/1995 | WO1995002687A1 Immortalized human fetal osteoblastic cells |
| 01/26/1995 | WO1995002686A1 Redirection of cellular immunity by receptor chimeras |
| 01/26/1995 | WO1995002685A1 Serum-free culture of progenitor cells |
| 01/26/1995 | WO1995002684A1 Regulated apoptosis |
| 01/26/1995 | WO1995002612A1 Monoclonal antibodies to egg yolk immunoglobulins (igy) |
| 01/26/1995 | WO1995002417A1 Methods for the cultivation of infectious laryngotracheitis virus and egg drop syndrome virus |
| 01/26/1995 | WO1995002319A1 Transgenic plants containing multiple disease resistance genes |
| 01/26/1995 | WO1994028126A3 Phenylalanine-free protein and dna coding therefor |
| 01/26/1995 | WO1994028125A3 Dna encoding prostaglandin receptor ep1 |
| 01/26/1995 | CA2167282A1 Regulated apoptosis |
| 01/26/1995 | CA2167214A1 Monoclonal antibodies to egg yolk immunoglobulins (igy) |
| 01/26/1995 | CA2167155A1 Modified alpha-lactalbumin |
| 01/26/1995 | CA2166405A1 Transgenic plants containing multiple disease resistance genes |
| 01/26/1995 | CA2144040A1 Defective adenovirus vectors and use thereof in gene therapy |
| 01/25/1995 | EP0635575A1 Monoclonal antibodies against epitopes found in free but not in alpha-1-antichmotrypsin complexed prostate specific antigen |
| 01/25/1995 | EP0635574A1 Selection marker gene free recombinant strains, a method for obtaining them and the use of these strains |
| 01/25/1995 | EP0635062A1 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS OF mRNA |
| 01/25/1995 | EP0635061A1 A method of limiting the survival of genetically engineered microorganisms in their environment |
| 01/25/1995 | EP0635054A1 Mammalian melanocyte stimulating hormone receptors and uses |
| 01/25/1995 | EP0635052A1 MONOCLONAL ANTIBODY TO CELL SURFACE PROTEIN OF THE BACTERIUM $i(STREPTOCOCCUS PNEUMONIAE) |
| 01/25/1995 | EP0635040A1 Crosslinked biocompatible encapsulation compositions and methods |
| 01/25/1995 | EP0635030A1 IMMUNOTOXINS DIRECTED AGAINST c-erbB-2 (HER-2/$i(neu)) RELATED SURFACE ANTIGENS |
| 01/25/1995 | EP0634936A1 Materials and methods for immunocontraception |
| 01/25/1995 | EP0634896A1 Evaluation and treatment of patients with progressive immunosuppression |
| 01/25/1995 | EP0483216B1 Preparation of human adherent lymphokine-activated killer (a-lak) cells |
| 01/24/1995 | US5384253 Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes |
| 01/24/1995 | US5383847 Non-specific immune system enhancement |
| 01/24/1995 | CA1334077C Monoclonal antibody recognizing human psti, hybridoma producing the antibody, and determination of human psti |
| 01/24/1995 | CA1334076C Monoclonal antibody recognizing atrial natriuretic polypeptide |
| 01/23/1995 | CA2128285A1 Monoclonal antibodies against prostate specific antigen that are not available in psa complexed to 1-antichymotrypsin |
| 01/20/1995 | CA2128151A1 Receptors of interleukin-12 and antibodies |
| 01/19/1995 | WO1995002069A1 Oligonucleotide modulation of protein kinase c |
| 01/19/1995 | WO1995002063A1 A method for producing taxol and taxanes from embryo cultures of taxus species |
| 01/19/1995 | WO1995002057A1 Protein tyrosine kinase and ligands thereof |